Cipla gets USFDA observations for its Goa plant Ruby Khatun Khatun21 March 2018 11:00 AM ISTNew Delhi: Drug firm Cipla said it has received observations from the US health regulator for its Goa plant which are procedural in nature.The United...
65 percent of misleading Ayush ads withdrawn following complaints: Parliamentary panel Ruby Khatun Khatun21 March 2018 10:30 AM ISTNew Delhi: Appreciating the efforts made by the AYUSH Ministry to monitor misleading advertisements on herbal products, a Parliamentary panel has...
Roche's Tecentriq notches third cancer cocktail trial win Ruby Khatun Khatun21 March 2018 10:00 AM ISTZURICH: Roche’s immunotherapy Tecentriq racked up a third trial win in combination with other cancer drugs, a boost for the Swiss drugmaker as it...
Karma Healthcare raises Rs 3 crore from 1Crowd, existing investors, and angel investors Ruby Khatun Khatun21 March 2018 10:00 AM ISTNew Delhi: Health tech startup Healthcare">Karma Healthcare raised Rs. 3 crore in equity funding from early-stage investment firm 1Crowd, existing...
Seattle Genetics Hodgkin's lymphoma drug wins US approval Ruby Khatun Khatun21 March 2018 9:30 AM ISTU.S. regulators approved Seattle Genetics Inc’s Adcetris as part of a chemotherapy cocktail to treat advanced Hodgkin’s lymphoma in newly diagnosed...
Methyldopa : Wockhardt under NPPA lens over essential BP medicine price Ruby Khatun Khatun20 March 2018 4:44 PM ISTNew Delhi: More trouble seems mounting for Wockhardt after the National Pharmaceutical Pricing Authority (NPPA) began an investigation against the...
Lupin gets USFDA nod for psoriasis treatment spray Ruby Khatun Khatun20 March 2018 11:00 AM ISTNew Delhi: Drug major Lupin said it has received approval from the US health regulator to market Desoximetasone Topical spray, used for the treatment...
Haryana govt to seek CAG audit of medical purchases after INLD allegations Ruby Khatun Khatun20 March 2018 10:30 AM ISTChandigarh: The Manohar Lal Khattar government in Haryana decided to seek a special CAG audit of medical purchases in state-run hospitals following...
Parliament panel pulls up DoP, NPPA for poor budgetary planning Ruby Khatun Khatun20 March 2018 10:00 AM ISTNew Delhi: A parliamentary panel has pulled up the Department of Pharmaceuticals (DoP) for poor budgetary planning and dissatisfactory fund...
Boehringer Ingelheim gets FDA Fast Track designation for nintedanib to treat SSc-ILD Ruby Khatun Khatun20 March 2018 9:30 AM ISTBoehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to nintedanib for the treatment of...
Biocon sees approvals unlocking 1 billion dollar biosimilar sales: Bloomberg Report Ruby Khatun Khatun20 March 2018 9:10 AM ISTBiocon Ltd., the only Indian drugmaker to win approval to sell copies of a biologic drug in the U.S., expects its business in that nascent sector will...
Rs 125 crore alleged medicine purchase scam in Haryana Ruby Khatun Khatun19 March 2018 11:30 AM ISTChandigarh: Haryana's main opposition Indian National Lok Dal (INLD) alleged there were irregularities to the tune of hundreds of crores in the...
